Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.4 (
trypsin
)
42,187
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The stability of acetyl-CoA synthetases (
ACS1
and ACS2) from P. blakesleeanus against temperature, urea and
trypsin
was studied and compared. Thermal inactivation of
ACS1
was biphasic, while that of ACS2 was monophasic. The thermodynamic parameters calculated from the inactivation profiles show ACS2 to be a more thermostable enzyme than
ACS1
. The presence of ATP and Mg(2+) exerted a protective effect on both enzymes, and led to a marked increase in the E(a), DeltaH(not =), DeltaS(not =) and DeltaG(not =) values. ACS2 is also much more stable against denaturation with urea; the estimates of DeltaG(w) (free energy change for protein unfolding at zero denaturant concentration) were 9.4 kJ mol(-1) and 18.1 kJ mol(-1) for
ACS1
and ACS2, respectively. Finally, a half-life of 44.5 min for ACS2 versus the 21 min for
ACS1
indicates that ACS2 is more stable than
ACS1
against digestion by
trypsin
. These results seem to show that ACS2 is more rigid overall than
ACS1
, which may be essential for preserving its catalytic activity in the stress situation in which it is expressed.
...
PMID:Different stabilities of two AMP-forming acetyl-CoA synthetases from Phycomyces blakesleeanus expressed under different environmental conditions. 1787 55